Author

Keying Ma

Observed names: K Ma, Ke-Ying Ma

Institution: Janssen Research & Development (United States)

Observed institutions: Johnson & Johnson (United States), Janssen Research & Development (United States), Case Western Reserve University

ORCID: 0000-0003-3454-9168

Observed ORCID: 0000-0003-3454-9168

OpenAlex ID: A5066386394

Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis

2009 · I Arijs, K Li, et al. · Gut · 412

PDF

High Affinity Binding of β2-Glycoprotein I to Human Endothelial Cells Is Mediated by Annexin II

2000 · Keying Ma, Ronit Simantov, et al. · Journal of Biological Chemistry · 213

PDF

Gene Expression Profiling and Response Signatures Associated With Differential Responses to Infliximab Treatment in Ulcerative Colitis

2011 · Gary Toedter, Katherine Li, et al. · The American Journal of Gastroenterology · 107

Molecular profiling and gene expression analysis in cutaneous sarcoidosis: The role of interleukin-12, interleukin-23, and the T-helper 17 pathway

2011 · Marc A. Judson, Richard M. Marchell, et al. · Journal of the American Academy of Dermatology · 85

Genes Associated with Intestinal Permeability in Ulcerative Colitis: Changes in Expression Following Infliximab Therapy

2012 · Gary Toedter, Katherine Li, et al. · Inflammatory Bowel Diseases · 45

Guselkumab induces robust reduction in acute phase proteins and type 17 effector cytokines in active psoriatic arthritis: results from phase 3 trials

2021 · Kristen Sweet, Qingxuan Song, et al. · RMD Open · 39

PDF

Guselkumab Reduces Disease- and Mechanism-Related Biomarkers More Than Adalimumab in Patients with Psoriasis: A VOYAGE 1 Substudy

2024 · Andrew Blauvelt, Richard G. Langley, et al. · JID Innovations · 5

Su1745 Characterization of Molecular Response to Golimumab in Ulcerative Colitis by mRNA Expression Profiling: Results From Pursuit-SC Induction Study

2013 · Katherine Li, Shannon Telesco, et al. · Gastroenterology · 2

PDF

251 Type II but not type I interferon signifies clinical response to ustekinumab in patients with systemic lupus erythematosus

2019 · Jarrat Jordan, Kristen Sweet, et al. · Lupus Science & Medicine · 1

PDF

978 Whole Blood mRNA Expression Profiling of Crohn's Disease in the Certifi Ustekinumab Study Discriminates Clinical Subtypes

2013 · Katherine Li, Carrie Brodmerkel, et al. · Gastroenterology · 1

W1228 Genes Associated With Reduced Epithelial Permeability and Epithelial-Mesenchymal Transition: Changes in Expression Following Infliximab Therapy in Ulcerative Colitis

2010 · Gary Toedter, Keying Ma, et al. · Gastroenterology · 1

PWE-084 Whole Blood MRNA Expression Profiling of Crohn’S Disease in the Certifi Ustekinumab Study Discriminates Clinical Subtypes

2013 · K Li, C Brodmerkel, et al. · Gut

PDF

PTH-099 Distinctive Gene Expression Profiles in the Whole Blood of Patients with Moderate to Severe Ulcerative Colitis and Crohn’S Disease

2013 · S Telesco, K Li, et al. · Gut

PDF

Su1763 Distinctive Gene Expression Profiles in the Whole Blood of Patients With Moderate to Severe Ulcerative Colitis and Crohn's Disease

2013 · Shannon Telesco, Katherine Li, et al. · Gastroenterology

PDF

S.23. Expression Profiling of Skin and Peripheral Blood Mononuclear Cells from Patients with Cutaneous Sarcoidosis: An Interleukin-12 and Interferon Signature

2009 · Carrie Brodmerkel, Richard Marchell, et al. · Clinical Immunology

Characterization of a synthetic antagonist and agonists of memory-enhancing peptide

1995 · Yu-Cang Du, An-Wu Zhou, et al. · Springer eBooks

Works count: 16

Citation count: 911

H-index: 6

I10-index: 6